NCT04495296 2025-12-19A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid TumorsSuzhou Transcenta Therapeutics Co., Ltd.Phase 1/2 Recruiting320 enrolled